Overview

Study Of Pharmacokinetics and Pharmacodynamics Effects Of GSK256073A On Healthy Volunteers

Status:
Completed
Trial end date:
2007-11-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare the effects of single and repeat doses of GSK256073 with placebo in HVT subjects.
Phase:
Phase 1
Details
Lead Sponsor:
GlaxoSmithKline